510(k) Report

510(k) · Cleared

Cleared

Silgel STC-S

K984029510(k) TraditionalCleared Aug 5, 1999266-day reviewClass I21 CFR 878.4025

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Nagor, Ltd. · MDA Elastomer, Silicone, For Scar Management

Cleared on Aug 5, 1999 as substantially equivalent to K954413 (Allied Biomedical Corp., 1995) after a 266-day review. Its family tree reaches back 1 generation to 1995.

Decided
Aug 5, 1999
Review
266 days
Class
Class I
Product code
MDA
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K954413 (1995). No later device cites it as a predicate yet.

K954413 · Kelocote · Allied Biomedical Corp. · 1995199619982000
K954413 · Kelocote · Allied Biomedical Corp. · 19950
  1. Root · 1 generation backK954413 KelocoteAllied Biomedical Corp. · 1995
  2. This deviceK984029 Silgel STC-SNagor, Ltd. · 1999
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K954413KelocoteAllied Biomedical Corp.1995—
0 (this device)K984029Silgel STC-SNagor, Ltd.1999—
FIG. 1 — Lineage of K984029, 1995–1999Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MDA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (5)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K954413Kelocote
Summary page 1
…ilicone gel Classification Name: Not classified 3. Predicate Devices The predicate devices are all silicone gels and include: Kelocote Gel [510 (k) registration number: K954413] Xeragel [S10 (k) number unknown] Zeraderm [510 (k) number unknown] Scar Fade [510 (k) number unknown] Spectragel [510 (k) number…
Allied Biomedical Corp.1995—
*—Xeragel
Named without a submission number
—
*—Zeraderm
Named without a submission number
—
*—Scar Fade
Named without a submission number
—
*—Spectragel
Named without a submission number
—

Also cleared against K954413: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • 1 other device also cites its predicate K954413.

How does its category compare?

All MDA devices

MDA Elastomer, Silicone, For Scar Management: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · MDA

2in 2011

2009: 12011: 2
2007high 2 (2011) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MDA

Too few MDA 510(k)s in any year since 2007 to give a median.

Recalls per year · MDA

No recall names MDA since 2007.

Adverse event reports per year · MDA

3in 2025

2007: 32013: 22014: 12015: 22016: 52017: 32018: 22019: 52020: 42021: 32023: 82025: 3
2007high 8 (2023) · low 0 (2008)2025

MAUDE reports naming product code MDA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—03
20080—00
20091—00
20100—00
20112—00
20120—00
20130—02
20140—01
20150—02
20160—05
20170—03
20180—02
20190—05
20200—04
20210—03
20220—00
20230—08
20240—00
20250—03
20260—0—

What is it indicated for?

Silgel™ STC-S is intended for use in the management of keloid and hypertrophic scars and associated erythema.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K984029: Silgel STC-S.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K984029

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026